ORAMED PHARMACEUTICALS INC (ORMP) Stock Analyst Earnings Estimates
NASDAQ:ORMP - Nasdaq - US68403P2039 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.7M -0.37% | 2.7M | 1.34M -50.37% | -100.00% | 1.02M | -100.00% | |||||
| EBITDA YoY % growth | -24.14M -105.45% | -40.54M -67.94% | -15.573M 61.59% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -24.22M -105.95% | -40.6M -67.63% | -15.769M 61.16% | -14.278M 9.45% | -19.788M -38.59% | -52.53M -165.46% | -53.652M -2.14% | -54.876M -2.28% | -56.1M -2.23% | -57.324M -2.18% | |
| Operating Margin | -897.04% | -1,503.70% | -1,176.79% | N/A | -1,940.00% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -0.78 -33.89% | -0.94 -21.05% | 0.14 114.89% | -0.04 -125.50% | -0.19 -442.86% | -1.29 -563.16% | -0.84 34.92% | -0.74 10.98% | -0.67 9.59% | -0.62 7.58% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 -107.73% | -0.05 -227.50% | -0.06 -123.54% | -0.07 85.13% | -0.08 -220.00% |
| Revenue Q2Q % growth | 510K | 510K | 510K | 510K | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.335M -11.81% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.48 -500.00% | 0.01 | -0.49 | -9,511.76% |
| Q2 2024 Q2Q % growth | 0.26 966.67% | 0.01 | 0.25 | 2,449.02% |
| Q1 2024 Q2Q % growth | 0.04 150.00% | 0.02 | 0.02 | 96.08% |
| Q4 2023 Q2Q % growth | 0.33 250.00% | -0.12 | 0.45 | 369.61% |
| Q3 2023 Q2Q % growth | -0.08 55.56% | -0.09 | 0.01 | 7.73% |
| Q2 2023 Q2Q % growth | -0.03 88.89% | -0.10 | 0.07 | 70.59% |
| Q1 2023 Q2Q % growth | -0.08 70.37% | -0.27 | 0.19 | 69.83% |
| Q4 2022 Q2Q % growth | -0.22 -6.51% | -0.23 | 0.01 | 5.40% |
| Q3 2022 Q2Q % growth | -0.18 -5.88% | -0.26 | 0.08 | 30.34% |
| Q2 2022 Q2Q % growth | -0.27 -58.82% | -0.22 | -0.05 | -21.70% |
| Q1 2022 Q2Q % growth | -0.27 -17.39% | -0.23 | -0.04 | -15.09% |
| Q4 2021 Q2Q % growth | -0.21 -72.13% | -0.17 | -0.04 | -22.73% |
| Q3 2021 Q2Q % growth | -0.17 -70.00% | -0.19 | 0.02 | 9.91% |
| Q2 2021 Q2Q % growth | -0.17 19.05% | -0.20 | 0.03 | 16.67% |
| Q1 2021 Q2Q % growth | -0.23 -53.33% | -0.18 | -0.05 | -28.85% |
| Q4 2020 Q2Q % growth | -0.12 7.69% | -0.15 | 0.03 | 18.86% |
| Q3 2020 Q2Q % growth | -0.10 56.52% | -0.21 | 0.11 | 52.56% |
| Q2 2020 Q2Q % growth | -0.21 | -0.17 | -0.04 | -22.91% |
| Q1 2020 Q2Q % growth | -0.15 40.00% | -0.18 | 0.03 | 15.97% |
| Q4 2019 Q2Q % growth | -0.13 | -0.25 | 0.12 | 47.98% |
| Q3 2019 Q2Q % growth | -0.23 | -0.25 | 0.02 | 7.96% |
| Q2 2019 Q2Q % growth | -0.21 | -0.24 | 0.03 | 11.76% |
| Q1 2019 Q2Q % growth | -0.25 | -0.24 | -0.01 | -2.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -100.00% | 255K | -255K | -100.00% |
| Q1 2024 Q2Q % growth | -100.00% | 510K | -510K | -100.00% |
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | 714K | -714K | -100.00% |
| Q2 2023 Q2Q % growth | 674K 0.60% | 714K | -40K | -5.60% |
| Q1 2023 Q2Q % growth | 666K -0.60% | 765K | -99K | -12.94% |
| Q4 2022 Q2Q % growth | 680K 1.49% | 736.644K | -56.644K | -7.69% |
| Q3 2022 Q2Q % growth | 680K | 706.35K | -26.35K | -3.73% |
| Q2 2022 Q2Q % growth | 670K -1.47% | 714K | -44K | -6.16% |
| Q1 2022 Q2Q % growth | 670K | 714K | -44K | -6.16% |
| Q4 2021 Q2Q % growth | 670K | 714K | -44K | -6.16% |
| Q3 2021 Q2Q % growth | 680K | 1.275M | -595K | -46.67% |
| Q2 2021 Q2Q % growth | 680K | 1.088M | -408K | -37.50% |
| Q1 2021 Q2Q % growth | 670K | 714K | -44K | -6.16% |
| Q4 2020 Q2Q % growth | 670K | 653.31K | 16.69K | 2.55% |
| Q3 2020 Q2Q % growth | 680K | 1.456M | -776K | -53.30% |
| Q2 2020 Q2Q % growth | 680K | 516.12K | 163.88K | 31.75% |
| Q1 2020 Q2Q % growth | 670K | 331.5K | 338.5K | 102.11% |
| Q4 2019 Q2Q % growth | 670K | 663K | 7K | 1.06% |
| Q3 2019 Q2Q % growth | 680K | 688.5K | -8.5K | -1.23% |
| Q2 2019 Q2Q % growth | 680K | 724.537K | -44.537K | -6.15% |
| Q1 2019 Q2Q % growth | 670K | 731.34K | -61.34K | -8.39% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 58.33% | 0% | -133.33% |
| Revenue | N/A | -100% | N/A | N/A |